Contact
Please use this form to send email to PR contact of this press release:
InterveXion Therapeutics Receives Japanese Patent for IXT-m200 (Anti-Methamphetamine Antibody)
TO:
Misty Stevens
InterveXion Therapeutics
+1 501-554-2377